Nephrocare Health Services (NSE: NEPHROPLUS) key facts
- Nephrocare Health Services Ltd is a dialysis services provider company.
- Nephrocare Health Services (NSE: NEPHROPLUS)’s last known valuation is $514.5M (Dec 2025).
- It has raised $267.3M across 1 recorded rounds; the latest was Later Stage VC (Series F) ($102.5M) in May 2024.
- Notable investors include International Finance (Washington D.C.), Quadria Capital, Kamet Capital, 360 ONE, Conifer Capital — 8 tracked in total.
- Status: Publicly Held.
Who backs Nephrocare Health Services (NSE: NEPHROPLUS)
8- ·Watch Nephrocare Health Services (NSE: NEPHROPLUS): the Monday email on marks, rounds and moves
Nephrocare Health Services (NSE: NEPHROPLUS) funding rounds
1 roundsNephrocare Health Services (NSE: NEPHROPLUS) valuation
Nephrocare Health Services (NSE: NEPHROPLUS) is now publicly traded; this page covers its private-market history, where its last recorded valuation was $515 million (Dec 2025). Secondary trades, fund marks and rounds below are the private-market record; the listed share price is not tracked here.
How much has Nephrocare Health Services (NSE: NEPHROPLUS) raised?
Nephrocare Health Services (NSE: NEPHROPLUS) has raised $267 million in total; 1 of its rounds is on record. The largest on record was a $103 million Series F in May 2024.
Nephrocare Health Services (NSE: NEPHROPLUS) investors
8 investors are on record for Nephrocare Health Services (NSE: NEPHROPLUS), including International Finance (Washington D.C.), Quadria Capital, Kamet Capital and 360 ONE. The Series F in May 2024 drew 4 investors.
Comparable companies
Comparable clinics/outpatient services names by valuation on PrivateMarketView: Headway (Clinics/Outpatient Services) ($2.3 billion), Galileo (Clinics/Outpatient Services) ($362 million) and Oshi Health ($200 million).
About Nephrocare Health Services (NSE: NEPHROPLUS)
Nephrocare Health Services Ltd is a dialysis services provider company. It offers comprehensive dialysis care through its network of clinics - from diagnosis to treatment and wellness programs including haemodialysis, home and mobile dialysis, supported by pharmacy. The company operates in a single segment, namely the provision of dialysis services and the sale of related healthcare products. It generates revenue by providing its dialysis and related services.
- Industry
- Clinics/Outpatient Services
- Sector
- Healthcare
- HQ
- Hyderabad, India
- Founded
- 2009
- Employees
- 5,850
- Website
- nephroplus.com/
- Ownership
- Publicly Held
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.
Nephrocare Health Services (NSE: NEPHROPLUS)’s last known valuation, Dec 2025. A PrivateMarketView mark is published once fund marks, secondary prints or a priced round let us confirm it.